fig2

Figure 2. Canagliflozin and sitagliptin therapy demonstrate comparable improvements in coronary perfusion to chronically ischemic myocardium. Perfusion expressed as mL/min/g as measured by microsphere analysis shown at rest and during pacing to 150 beats/min in pigs receiving canagliflozin (CANA, eight animals), sitagliptin (SIT, five animals), or vehicle with no drug (CON, eight animals). **signifies a P value of less than 0.01.